These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7229929)

  • 21. Activity of 17 beta-hydroxy-3-aza-A-homo-4 alpha-androsten-4-one-p-N, N-bis(2-chloroethyl)aminophenoxyacetate (NSC-620480) in P388 leukemia. Activity of steroidal lactams in Ehrlich tumor.
    Catsoulacos P; Pairas G
    Methods Find Exp Clin Pharmacol; 1990 Sep; 12(7):501-5. PubMed ID: 2087151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative studies on the chemical stability and therapeutic effectiveness of water-insoluble 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) and its water-soluble hydrochloride against L1210 mouse leukemia.
    Woodman RJ; Kline I; Field RB; Gang M
    Cancer Chemother Rep; 1973; 57(4):383-91. PubMed ID: 4762437
    [No Abstract]   [Full Text] [Related]  

  • 23. Differential susceptibility and cytopathic alterations induced by PTT. 119, a new cancericidal compound, p-fluoro-Phe-L-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl.
    Yagi MJ; Bekesi JG
    Biomed Pharmacother; 1983; 37(7):329-38. PubMed ID: 6667339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Action of nitrosoalkylureas and the longevity of tumor-bearing animals].
    Krutova TV; Kondradov AA; Ostrovskaia LA
    Izv Akad Nauk SSSR Biol; 1983; (6):843-50. PubMed ID: 6655115
    [No Abstract]   [Full Text] [Related]  

  • 25. Conjugated system of homo-aza-steroidal esters in cancer chemotherapy.
    Catsoulacos P; Catsoulacos D
    Anticancer Res; 1994; 14(6B):2525-8. PubMed ID: 7872677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-Farnesyloxy-norcantharimide and N-farnesyl-norcantharimide inhibit the progression of leukemia and increase survival days in a syngeneic mouse leukemia model.
    Chang MC; Tsai ET; Wu JY; Liao HF; Chen YJ; Kuo CD
    Anticancer Drugs; 2015 Jun; 26(5):508-17. PubMed ID: 25588161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential antitumor agents: steroidal amidoesters with an alkylating moiety.
    Papageorgiou A; Boutis L; Nicolaropoulos S; Catsoulacos P
    Oncology; 1987; 44(2):128-32. PubMed ID: 3574853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of cytotoxicity of single dose and infusion of alkylating agents.
    Valeriote F; Vietti T
    Cancer Drug Deliv; 1985; 2(1):11-8. PubMed ID: 4052923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of mutagenicity, antitumor activity, and chemical properties of selected nitrosoureas and nitrosoamides.
    Brundrett RB; Colvin M; White EH; McKee J; Hartman PE; Brown DL
    Cancer Res; 1979 Apr; 39(4):1328-33. PubMed ID: 421216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy of advanced L1210 leukemia with platinum compounds in combination with other antitumor agents.
    Gale GR; Atkins LM; Meischen SJ; Smith AB; Walker EM
    Cancer Treat Rep; 1977; 61(3):445-50. PubMed ID: 872142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic antileukemic effect of theophylline and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    DeWys WD; Bathina SH
    Cancer Res; 1980 Jul; 40(7):2202-8. PubMed ID: 6248198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor activity of homo-aza-steroidal esters of p-N, N-bis(2-chloroethyl)aminophenoxyacetic acid.
    Catsoulacos P; Catsoulacos D
    Anticancer Res; 1993; 13(4):1203-8. PubMed ID: 8352545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential antitumor agent: steroidal bilactam ester of p-N, N-bis (2-chloroethyl) aminophenylacetic acid.
    Catsoulacos P; Camoutsis C; Papageorgiou A
    Anticancer Res; 1995; 15(3):827-30. PubMed ID: 7645966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and evaluation of antitumor activity of 1-[N, N-bis(2-chloroethyl) sulfamoylphenyl]-3,3-dialkyltriazenes.
    Lalezari I; Afghahi F
    J Pharm Sci; 1975 Apr; 64(4):698-9. PubMed ID: 1142087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative prediction of drug toxicity in humans from toxicology in small and large animals.
    Goldsmith MA; Slavik M; Carter SK
    Cancer Res; 1975 May; 35(5):1354-64. PubMed ID: 804350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antileukemic effect of homo-aza-steroidal ester of [p-[bis(2-chloroethyl)amino]phenyl]acetic acid.
    Wampler GL; Catsoulacos P
    Cancer Treat Rep; 1977; 61(1):37-41. PubMed ID: 861962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of dose interval on the survival of L1210 leukemic mice treated with DNA synthesis inhibitors.
    Neil GL; Homan ER
    Cancer Res; 1973 Apr; 33(4):895-901. PubMed ID: 4696483
    [No Abstract]   [Full Text] [Related]  

  • 38. Deferasirox shows in vitro and in vivo antileukemic effects on murine leukemic cell lines regardless of iron status.
    Lee DH; Jang PS; Chung NG; Cho B; Jeong DC; Kim HK
    Exp Hematol; 2013 Jun; 41(6):539-46. PubMed ID: 23415674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Kinetic study of the effect of N-nitroso-N-alkylurea on the development of leukemia L1210].
    Ostrovskaia LA; Sokolova IS; Gorbacheva LB
    Vopr Onkol; 1977; 23(3):59-63. PubMed ID: 898797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An in vitro assay for evaluating chemosensitivity of leukaemia cells: preclinical studies.
    Menconi E; Lepri E; Bonmassar E; Frati L; Barzi A
    Int J Tissue React; 1986; 8(6):485-92. PubMed ID: 3793386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.